Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection
Heiner Wedemeyer,Xiao-Song He,Michelina Nascimbeni,Anthony R. Davis,Harry B. Greenberg,Jay H. Hoofnagle,T. Jake Liang,Harvey J. Alter,Barbara Rehermann +8 more
Reads0
Chats0
TLDR
The defective functions of HCV-specific CD8+ T cells might contribute to viral persistence in chronically infected patients, and knowledge on their reversibility may facilitate the development of immunotherapeutic vaccines.Abstract:
The cellular immune response contributes to clearance of hepatitis C virus (HCV) and persists for decades after recovery from infection The immunological basis for the inefficiency of the cellular immune response in chronically infected persons is not known Here, we used four HLA-A2 tetramers, specific for two HCV core and two HCV NS3 epitopes, to investigate at the single-cell level effector function and phenotype of HCV-specific CD8+ T cells in 20 chronically infected and 12 long-term recovered patients Overall, HCV-specific, tetramer+ T cells were more frequently found in PBMCs of chronically infected patients than in those of recovered patients However, when compared with HCV-tetramer+ T cells of recovered patients, they displayed an impaired proliferative capacity As a result of the impaired proliferative capacity, HCV-specific T cell lines derived from chronically infected patients displayed less peptide-specific cytotoxicity than those from recovered patients In addition, proliferation and ex vivo IFN-gamma production of HCV-tetramer+ cells, but not influenza-virus-specific T cells, were defective in chronically infected patients and could not be restored by in vitro stimulation with peptide and IL-2 At least three distinct phenotypes of HCV-specific CD8+ T cells were identified and associated with certain functional characteristics In addition, impairment of proliferative, cytokine, and cytotoxic effector functions of tetramer+ T cells in viremic patients was associated with weak ex vivo HCV-specific CD4+ T cell responses Thus, the defective functions of HCV-specific CD8+ T cells might contribute to viral persistence in chronically infected patients, and knowledge on their reversibility may facilitate the development of immunotherapeutic vaccinesread more
Citations
More filters
Journal ArticleDOI
Viral hepatitis B
TL;DR: Current available monotherapies-interferon, lamivudine, and adefovir dipivoxil-very rarely eradicate the virus, but greatly reduce its replication, necroinflammatory histological activity, and progression of fibrosis.
Journal ArticleDOI
Immunology of hepatitis B virus and hepatitis C virus infection.
TL;DR: This review assesses recent advances in the understanding of viral hepatitis, contrasts mechanisms of virus–host interaction in acute hepatitis B and hepatitis C, and outlines areas for future studies.
Journal ArticleDOI
Memory CD8 T-Cell Differentiation during Viral Infection
E. John Wherry,Rafi Ahmed +1 more
TL;DR: Memory CD8 T cells are an important component of protective immunity against viral infections, and understanding their development will aid in the design of optimal vaccines.
Journal ArticleDOI
Viral hepatitis C
TL;DR: Genotype and serum viral load are useful predictors of response to treatment and the combination of pegylated interferon and ribavirin can eradicate the virus in more than 50% of patients.
Journal ArticleDOI
The Liver as a Lymphoid Organ
TL;DR: The liver receives blood from both the systemic circulation and the intestine, and in distinctive, thin-walled sinusoids this mixture passes over a large macrophage population, termed Kupffer cells, which has resulted in a distinctive local immune environment.
References
More filters
Journal ArticleDOI
Phenotypic Analysis of Antigen-Specific T Lymphocytes
John D. Altman,Paul Moss,Philip J. R. Goulder,Dan H. Barouch,Michael G. McHeyzer-Williams,John I. Bell,Andrew J. McMichael,Mark M. Davis +7 more
TL;DR: Tetramers of human lymphocyte antigen A2 that were complexed with two different human immunodeficiency virus (HIV)-derived peptides or with a peptide derived from influenza A matrix protein bound to peptide-specific cytotoxic T cells in vitro and to T cells from the blood of HIV-infected individuals and correlated well with cytotoxicity assays.
Journal ArticleDOI
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Sally R.M. Bennett,Sally R.M. Bennett,Francis R. Carbone,Freda Karamalis,Freda Karamalis,Richard A. Flavell,Jacques F. A. P. Miller,William R. Heath +7 more
TL;DR: It is shown that signalling through CD40 on the antigen-presenting cells can replace the requirement for TH cells, indicating that T-cell ‘help’, at least for generation of CTLs by cross-priming, is mediated by signalling throughCD40 onThe antigen- presenting cell.
Journal ArticleDOI
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Allan J. Zajac,Joseph N. Blattman,Kaja Murali-Krishna,David J. D. Sourdive,M. Suresh,John D. Altman,Rafi Ahmed +6 more
TL;DR: The persistence of activated virus-specific CD8 T cells without effector function reveals a novel mechanism for silencing antiviral immune responses and also offers new possibilities for enhancingCD8 T cell immunity in chronically infected hosts.
Journal ArticleDOI
Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells
Dörte Hamann,Paul A. Baars,M.H.G. Rep,Berend Hooibrink,Susana R. Kerkhof-Garde,Michèl R. Klein,René A. W. van Lier +6 more
TL;DR: In this article, two discrete primed subpopulations are found within the circulating human CD8+ T cell subset, i.e., CD45RA−CD45R0+ cells and CD27−CD27− cells.
Journal ArticleDOI
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Franziska Lechner,David Wong,P R Dunbar,Roger W. Chapman,Raymond T. Chung,P B Dohrenwend,Gregory K. Robbins,Rodney E. Phillips,Paul Klenerman,Bruce D. Walker +9 more
TL;DR: A strong and persistent CTL response in resolving acute HCV infection is demonstrated, and rationale to explore immune augmentation as a therapeutic intervention in chronic HCv infection is provided.